Non-clinical safety evaluation of single and repeated intramuscular administrations of MAGE-A3 Cancer Immunotherapeutic in rabbits and cynomolgus monkeys
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-clinical safety evaluation of single and repeated intramuscular administrations of MAGE-A3 Cancer Immunotherapeutic in rabbits and cynomolgus monkeys
Authors
Keywords
-
Journal
JOURNAL OF APPLIED TOXICOLOGY
Volume 35, Issue 7, Pages 717-728
Publisher
Wiley
Online
2014-09-13
DOI
10.1002/jat.3025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor Mouse Model Confirms MAGE-A3 Cancer Immunotherapeutic As an Efficient Inducer of Long-Lasting Anti-Tumoral Responses
- (2014) Catherine Gérard et al. PLoS One
- Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
- (2013) Wim H.J. Kruit et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunotherapy of cancer in 2012
- (2012) John M. Kirkwood et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Bioinformatics for cancer immunology and immunotherapy
- (2012) Pornpimol Charoentong et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines
- (2011) Marijo Bilusic et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Outlining novel cellular adjuvant products for therapeutic vaccines against cancer
- (2011) Josianne Nitcheu Tefit et al. Expert Review of Vaccines
- Relationship of therapeutic cancer vaccine development to population disease burden and five-year survival
- (2011) Elias J. Dayoub et al. Human vaccines & immunotherapeutics
- Expression profile of cancer-testis genes in transitional cell carcinoma of the bladder
- (2011) Bo Yin et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Vaccines and Immunotherapeutics for the Treatment of Malignant Disease
- (2010) Joel F. Aldrich et al. Clinical & Developmental Immunology
- Targeting inhibitory pathways in cancer immunotherapy
- (2010) Marcio O Lasaro et al. CURRENT OPINION IN IMMUNOLOGY
- Strategies for Cancer Vaccine Development
- (2010) Matteo Vergati et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvants for cancer vaccines
- (2010) Thomas W. Dubensky et al. SEMINARS IN IMMUNOLOGY
- Whole tumor antigen vaccines
- (2010) Cheryl Lai-Lai Chiang et al. SEMINARS IN IMMUNOLOGY
- Histopathological lesions following intramuscular administration of saline in laboratory rodents and rabbits
- (2008) Celine Thuilliez et al. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
- Cancer Immunology
- (2008) Olivera J. Finn NEW ENGLAND JOURNAL OF MEDICINE
- Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming
- (2008) D. Atanackovic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search